Ove Törring

About me
Publications
Public outreach and news

Research

*Clinical endocrinology, thyreoidea, osteoporosis, adrenal glands*
Current projects include: Optimising the diagnostics and treatment of primary
hyperaldosteronism, quality of life of patients with thyreotoxicosis,
incidence of thyreotoxicosis in Sweden, subclinical hypothyreosis and
evaluating the osteoporosis fracture chain.

Articles

Article: THYROID. 2019;29(11):1545-1557

The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.

Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Article: THYROID. 2019;29(3):322-331

Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.

Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Article: JOURNAL OF THE ENDOCRINE SOCIETY. 2019;3(2):387-396

Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia.

Hedberg F; Pilo C; Wikner J; Törring O; Calissendorff J
Article: BRITISH JOURNAL OF SURGERY. 2018;105(3):279-286

All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism.

Giesecke P; Frykman V; Wallin G; Lönn S; Discacciati A; Törring O; Rosenqvist M
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2018;33(2):190-198

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.

Cummings SR; Ferrari S; Eastell R; Gilchrist N; Jensen J-EB; McClung M; Roux C; Törring O; Valter I; Wang AT; Brown JP
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2017;177(4):369-378

Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.

Andersen SL; Lönn S; Vestergaard P; Törring O
Article: THYROID. 2017;27(7):878-885

Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.

Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Article: EUROPEAN THYROID JOURNAL. 2016;5(1):50-56

Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations.

Lantz M; Calissendorff J; Träisk F; Tallstedt L; Planck T; Törring O; Hallengren B; Åsman P
Article: OSTEOPOROSIS INTERNATIONAL. 2015;26(12):2763-2771

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.

Ferrari S; Adachi JD; Lippuner K; Zapalowski C; Miller PD; Reginster J-Y; Törring O; Kendler DL; Daizadeh NS; Wang A; O'Malley CD; Wagman RB; Libanati C; Lewiecki EM
Article: LAKARTIDNINGEN. 2015;112:DF37

[Vitamin D intoxication caused by drugs bought online. Sky high daily dosage for six months resulted in severe hypercalcemia].

Mannheimer B; Törring O; Nathanson D
Article: QUALITY OF LIFE RESEARCH. 2015;24(3):769-780

Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO.

Watt T; Barbesino G; Bjorner JB; Bonnema SJ; Bukvic B; Drummond R; Groenvold M; Hegedüs L; Kantzer V; Lasch KE; Marcocci C; Mishra A; Netea-Maier R; Ekker M; Paunovic I; Quinn TJ; Rasmussen ÅK; Russell A; Sabaretnam M; Smit J; Törring O; Zivaljevic V; Feldt-Rasmussen U
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2014;99(9):3217-3223

Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism.

Ohrling H; Törring O; Yin L; Iliadou AN; Tullgren O; Abraham-Nordling M; Wallin G; Hall P; Lönn S
Article: JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. 2014;72(1):76-82

Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.

Ulmner M; Jarnbring F; Törring O
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2013;28(4):746-752

Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial.

Brown JP; Roux C; Törring O; Ho P-R; Beck Jensen J-E; Gilchrist N; Recknor C; Austin M; Wang A; Grauer A; Wagman RB
Article: MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 2013;20(2):130-137

Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.

Simon JA; Recknor C; Moffett AH; Adachi JD; Franek E; Lewiecki EM; McClung MR; Mautalen CA; Ragi-Eis S; Nicholson GC; Muschitz C; Nuti R; Törring O; Wang A; Libanati C
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2012;27(1):211-218

Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis.

McClung MR; Boonen S; Törring O; Roux C; Rizzoli R; Bone HG; Benhamou C-L; Lems WF; Minisola S; Halse J; Hoeck HC; Eastell R; Wang A; Siddhanti S; Cummings SR
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2011;165(6):899-905

Incidence of hyperthyroidism in Sweden.

Abraham-Nordling M; Byström K; Törring O; Lantz M; Berg G; Calissendorff J; Nyström HF; Jansson S; Jörneskog G; Karlsson FA; Nyström E; Ohrling H; Orn T; Hallengren B; Wallin G
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2011;96(6):1727-1736

Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk.

Boonen S; Adachi JD; Man Z; Cummings SR; Lippuner K; Törring O; Gallagher JC; Farrerons J; Wang A; Franchimont N; San Martin J; Grauer A; McClung M
Article: CLINICAL ENDOCRINOLOGY. 2011;74(2):174-180

Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism.

Persson A; Bollerslev J; Rosen T; Mollerup CL; Franco C; Isaksen GA; Ueland T; Jansson S; Caidahl K; SIPH Study Group
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2010;163(4):651-657

Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine.

Abraham-Nordling M; Wallin G; Träisk F; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Asman P; Lundell G; Törring O; Thyroid Study Group of TT 96
Article: LAKARTIDNINGEN. 2010;107(9):574-575

[Denosumab efficient against osteoporosis. A biological drug gives new possibilities to treat a public disease].

Törring O
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2009;94(10):3700-3707

Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.

Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G; Thyroid Study Group of TT 96
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2009;361(8):756-765

Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C; FREEDOM Trial
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2009;94(7):2255-2261

Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.

Bollerslev J; Rosen T; Mollerup CL; Nordenström J; Baranowski M; Franco C; Pernow Y; Isaksen GA; Godang K; Ueland T; Jansson S; SIPH Study Group
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2009;160(3):437-441

Hyperthyroidism and suicide: a retrospective cohort study in Sweden.

Abraham-Nordling M; Lönn S; Wallin G; Yin L; Nyren O; Tullgren O; Hall P; Törring O
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2008;158(6):823-827

Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005.

Abraham-Nordling M; Törring O; Lantz M; Hallengren B; Ohrling H; Lundell G; Calissendorff J; Jörneskog G; Wallin G
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2008;158(1):69-75

TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.

Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Article: SCANDINAVIAN JOURNAL OF SURGERY. 2008;97(3):248-253

The role of adrenal scintigraphy in the preoperative management of primary aldosteronism.

Volpe C; Enberg U; Sjögren A; Wahrenberg H; Jacobsson H; Törring O; Hamberger B; Thorén M
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2007;357(18):1799-1809

Zoledronic acid and clinical fractures and mortality after hip fracture.

Lyles KW; Colón-Emeric CS; Magaziner JS; Adachi JD; Pieper CF; Mautalen C; Hyldstrup L; Recknor C; Nordsletten L; Moore KA; Lavecchia C; Zhang J; Mesenbrink P; Hodgson PK; Abrams K; Orloff JJ; Horowitz Z; Eriksen EF; Boonen S; HORIZON Recurrent Fracture Trial
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2007;92(5):1687-1692

Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Bollerslev J; Jansson S; Mollerup CL; Nordenström J; Lundgren E; Tørring O; Varhaug J-E; Baranowski M; Aanderud S; Franco C; Freyschuss B; Isaksen GA; Ueland T; Rosen T
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2007;156(2):173-179

Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease.

Abraham-Nordling M; Wallin G; Lundell G; Törring O
Article: THYROID. 2005;15(11):1279-1286

Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery.

Abraham-Nordling M; Törring O; Hamberger B; Lundell G; Tallstedt L; Calissendorff J; Wallin G
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2004;58(10):1420-1424

Calcium and vitamin D3 supplements in calcium and vitamin D3 sufficient early postmenopausal healthy women.

Tfelt-Hansen J; Tørring O
Article: CALCIFIED TISSUE INTERNATIONAL. 2004;74(5):486-491

Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells.

Tsai JA; Janson A; Bucht E; Kindmark H; Marcus C; Stark A; Zemack HR; Torring O
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2004;60(2):121-126

Drug use and increased HbA1c levels in non-diabetic very elderly persons: the Kungsholmen project.

Passare G; Fastbom J; Törring O; Viitanen M
Article: CLINICAL DRUG INVESTIGATION. 2004;24(9):535-544

Sodium and potassium disturbances in the elderly : prevalence and association with drug use.

Passare G; Viitanen M; Törring O; Winblad B; Fastbom J
Article: HORMONE AND METABOLIC RESEARCH. 2004;36(1):22-26

Extracellular calcium increases free cytoplasmic calcium and DNA synthesis in human osteoblasts.

Tsai JA; Bucht E; Torring O; Kindmark H
Article: LAKARTIDNINGEN. 2001;98(42):4552-4553

[New, pioneering PTH treatment of postmenopausal osteoporosis. Quick effect on bone density and bone formation].

Törring O
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2001;61(5):395-400

Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women.

Tfelt-Hansen J; Schwarz P; Torring O
Article: CALCIFIED TISSUE INTERNATIONAL. 2000;66(5):363-369

Interleukin-1beta upregulates PTHrP-mRNA expression and protein production and decreases TGF-beta in normal human osteoblast-like cells.

Tsai JA; Rong H; Torring O; Matsushita H; Bucht E
Article: THYROID. 1998;8(8):653-659

Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study.

Ljunggren JG; Törring O; Wallin G; Taube A; Tallstedt L; Hamberger B; Lundell G
Article: LAKARTIDNINGEN. 1998;95(24):2820-2822

[The man behind Paget's syndrome. He gave name to diseases of the skeleton, breast and vulva].

Tørring O; Flam F; Larson B; Silfverswärd C
Article: CALCIFIED TISSUE INTERNATIONAL. 1998;62(3):250-254

Parathyroid hormone-related protein (1-37) induces cAMP response in human osteoblast-like cells.

Tsai JA; Bucht E; Stark A; Sjöstedt U; Törring O
Article: SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS. 1997;7(3):152-159

Effect of acute endurance and strength exercise on circulating calcium-regulating hormones and bone markers in young healthy males.

Rong H; Berg U; Tørring O; Sundberg CJ; Granberg B; Bucht E
Article: LAKARTIDNINGEN. 1996;93(36):3050-3052

[Osteoporosis is a suspected adverse effect of amiodarone].

Linde C; Rosenqvist M; Törring O
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(8):2986-2993

Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.

Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
Article: OSTEOPOROSIS INTERNATIONAL. 1996;6(5):394-398

Circulating monomer-like calcitonin in osteoporotic patients.

Rong H; Sääf M; Tørring O; Sjöstedt U; Bucht E
Article: OSTEOPOROSIS INTERNATIONAL. 1996;6(1):69-75

International comparison of hip fracture rates in 1988-89.

Bacon WE; Maggi S; Looker A; Harris T; Nair CR; Giaconi J; Honkanen R; Ho SC; Peffers KA; Torring O; Gass R; Gonzalez N
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 1995;132(4):438-443

Midmolecular parathyroid hormone-related peptide in serum during pregnancy, lactation and in umbilical cord blood.

Bucht E; Rong H; Bremme K; Granberg B; Rian E; Tørring O
Article: CALCIFIED TISSUE INTERNATIONAL. 1995;56(1):32-37

Serum calcitonin forms and concentrations in young and elderly healthy females.

Bucht E; Rong H; Sjöberg HE; Sjöstedt U; Granberg B; Tørring O
Show more

All other publications

Review: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2015;7(3):88-102

Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis.

Törring O
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:65

DENOSUMAB DISCONTINUATION AND ASSOCIATED FRACTURE INCIDENCE: ANALYSIS FROM THE FREEDOM TRIAL

Torring O; Brown J; Jensen J-EB; Gilchrist N; Recknor C; Roux C; Austin M; Wang A; Grauer A; Ho P-R; Wagman R
Meeting abstract: BONE. 2012;50:S54-S55

Denosumab effects on radius BMD, estimated strength, and wrist fractures: 3-year results from the FREEDOM study

Torring O; Simon J; Recknor C; Moffet A; Adachi J; Franek E; Lewiecki E; Mautalen C; Ragi Eis S; Nicholson G; Muschitz C; Nuti R; Wang A; Libanati C
Review: CURRENT DRUG SAFETY. 2011;6(2):62-74

Emerging anabolic treatments in osteoporosis.

Mosekilde L; Tørring O; Rejnmark L
Meeting abstract: BONE. 2010;46:S27-S28

Effect of Denosumab on the Incidence of Hip and New Vertebral Fractures in Postmenopausal Women With High Fracture Risk: A Subanalysis of the FREEDOM Study

Lippuner K; Adachi J; Cummings S; Man Z; Farrerons J; Torring O; Gallagher J; McClung M; Franchimont N; San Martin J; Wang A; Boonen S
Review: LAKARTIDNINGEN. 2001;98(28-29):3220-3224

[Osteoporosis among the elderly is a "silent epidemics". Insufficient prophylaxis and underdiagnosing are big problems].

Törring O

Research

Articles

All other publications

News from KI

Events from KI